Eleven Therapeutics vs FORE Biotherapeutics
Eleven Therapeutics vs FORE Biotherapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Eleven Therapeutics is on 56/100 and FORE Biotherapeutics on 56/100.
Where each one leads
Eleven Therapeutics
- headcount growth: +17.6% against +8.2%
FORE Biotherapeutics
- domain rating: 35/100 against 13/100
- headcount: 56 against 28
- funding raised: $232M against $22.0M
At a glance
| Measure | Eleven Therapeutics | FORE Biotherapeutics |
|---|---|---|
| What it is | Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Healthcare, Life Sciences, Therapeutics, Biotech | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2017 | 2011 |
| Headquarters | London, United Kingdom | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Eleven Therapeutics | FORE Biotherapeutics |
|---|---|---|
| Employees | 28 | 56 |
| Headcount growthLast 12 months | +17.6% | +8.2% |
| Open roles | 4 | Not published |
| Total funding | $22.0M | $232M |
| Latest round | Seed | Series D-2 Extension |
| Valuation | Not published | $75.0M |
| LinkedIn followers | 5,528 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Eleven Therapeutics | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 56/100 |
| Traction | 51/100 | 58/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 30/100 | 38/100 |
| Quality | 58/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Eleven Therapeutics | FORE Biotherapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
Eleven Therapeutics vs FORE Biotherapeutics: common questions
Which is better, Eleven Therapeutics or FORE Biotherapeutics?
Both score the same on our 0-100 rating, so the choice comes down to the 20 data points in the tables above rather than overall company strength.
How do Eleven Therapeutics and FORE Biotherapeutics compare on the numbers?
Eleven Therapeutics leads on headcount growth (+17.6% against +8.2%). FORE Biotherapeutics leads on domain rating (35/100 against 13/100), headcount (56 against 28), funding raised ($232M against $22.0M).
Read the full Eleven Therapeutics review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Eleven Therapeutics alternatives we track.